China Viral Vector Market (2025-2031) | Industry, Segmentation, Growth, Value, Analysis, Forecast, Size & Revenue, Share, Companies, Outlook, Competitive Landscape, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Viral Vector Market Revenues & Volume, 2021 & 2031F

3.3 China Viral Vector Market - Industry Life Cycle

3.4 China Viral Vector Market - Porter's Five Forces

3.5 China Viral Vector Market Revenues & Volume Share, By Vector Type, 2021 & 2031F

3.6 China Viral Vector Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 China Viral Vector Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investments in research and development for gene therapy and gene editing technologies.

4.2.2 Rising prevalence of genetic disorders and chronic diseases driving the demand for viral vectors in China.

4.2.3 Growing government support and initiatives to promote the development and adoption of gene therapy in the country.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and approval processes for viral vector-based therapies in China.

4.3.2 Limited manufacturing capacity and challenges in scaling up production to meet the growing demand.

4.3.3 Concerns regarding the safety and efficacy of viral vector-based therapies among healthcare professionals and patients.

6.1 China Viral Vector Market, By Vector Type

6.1.1 Overview and Analysis

6.1.2 China Viral Vector Market Revenues & Volume, By Vector Type, 2021- 2031F

6.1.3 China Viral Vector Market Revenues & Volume, By Adeno-associated Virus (AAV), 2021- 2031F

6.1.4 China Viral Vector Market Revenues & Volume, By Adenovirus, 2021- 2031F

6.1.5 China Viral Vector Market Revenues & Volume, By Lentivirus, 2021- 2031F

6.1.6 China Viral Vector Market Revenues & Volume, By Retrovirus, 2021- 2031F

6.1.7 China Viral Vector Market Revenues & Volume, By Others, 2021- 2031F

6.2 China Viral Vector Market, By Application

6.2.1 Overview and Analysis

6.2.2 China Viral Vector Market Revenues & Volume, By Cell & Gene Therapy, 2021- 2031F

6.2.3 China Viral Vector Market Revenues & Volume, By Vaccine, 2021- 2031F

6.2.4 China Viral Vector Market Revenues & Volume, By Biopharmaceutical & Pharmaceutical Discovery, 2021- 2031F

6.3 China Viral Vector Market, By End User

6.3.1 Overview and Analysis

6.3.2 China Viral Vector Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F

6.3.3 China Viral Vector Market Revenues & Volume, By Academics & Research Institutes, 2021- 2031F

6.3.4 China Viral Vector Market Revenues & Volume, By CROs & CMOs, 2021- 2031F

7.1 China Viral Vector Market Export to Major Countries

7.2 China Viral Vector Market Imports from Major Countries

8.1 Number of clinical trials using viral vectors in China.

8.2 Adoption rate of gene therapy and gene editing technologies in the healthcare sector.

8.3 Investment in infrastructure and manufacturing facilities for viral vector production in China.

9.1 China Viral Vector Market Opportunity Assessment, By Vector Type, 2021 & 2031F

9.2 China Viral Vector Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 China Viral Vector Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 China Viral Vector Market Revenue Share, By Companies, 2024

10.2 China Viral Vector Market Competitive Benchmarking, By Operating and Technical Parameters